![]()
|
|
||||||||
J Biol Chem, Vol. 273, Issue 46, 30398-30405, November 13, 1998
From the Institute of General Microbiology, University of Bern,
Baltzer-Strasse 4, CH-3012 Bern, Switzerland
The mismatch-binding activity Cmb1 of
Schizosaccharomyces pombe was enriched from wild type
cells, and N-terminal sequencing enabled cloning of the respective
gene. The deduced amino acid sequence of cmb1+
contains a high mobility group domain, a motif that is common to a
heterogeneous family of DNA-binding proteins. In crude protein extracts
of a cmb1 gene-disruption strain, specific binding to C/T,
C/A, and C/
The High Mobility Group Domain Protein Cmb1 of
Schizosaccharomyces pombe Binds to Cytosines in Base
Mismatches and Opposite Chemically Altered Guanines
was abolished. Weak binding to C/C revealed the presence
of a second mismatch-binding activity, Cmb2. Cmb1, enriched from
S. pombe and purified from Escherichia coli,
bound specifically to C/C, C/T, C/A, T/T, and C/
but showed little or no affinity to other mismatches and small loops. Cmb1 recognizes 1,2 GpG intrastrand cross-links, produced by the chemotherapeutic drug
cisplatin, when two cytosines are opposite the cross-linked guanines
but not when other bases are present. Consistently,
O6-methylguanine:C but not O6-methylguanine/T
lesions were bound. Thus, cytosines in mismatches and opposite
chemically modified guanines are the preferred target of Cmb1
recognition. cmb1 mutant cells are more sensitive to
cisplatin than wild type cells, indicating a role of Cmb1 in repair of
cisplatin-induced DNA damage.
Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
R. Muheim-Lenz, T. Buterin, G. Marra, and H. Naegeli Short-patch correction of C/C mismatches in human cells Nucleic Acids Res., December 21, 2004; 32(22): 6696 - 6705. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Yuan, L. Gu, S. Guo, C. Wang, and G.-M. Li Evidence for Involvement of HMGB1 Protein in Human DNA Mismatch Repair J. Biol. Chem., May 14, 2004; 279(20): 20935 - 20940. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Perego, G. S. Jimenez, L. Gatti, S. B. Howell, and F. Zunino Yeast Mutants As a Model System for Identification of Determinants of Chemosensitivity Pharmacol. Rev., December 1, 2000; 52(4): 477 - 492. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Nakahara, Q.-M. Zhang, K. Hashiguchi, and S. Yonei Identification of proteins of Escherichia coli and Saccharomyces cerevisiae that specifically bind to C/C mismatches in DNA Nucleic Acids Res., July 1, 2000; 28(13): 2551 - 2556. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. T. Yarnell, S. Oh, D. Reinberg, and S. J. Lippard Interaction of FACT, SSRP1, and the High Mobility Group (HMG) Domain of SSRP1 with DNA Damaged by the Anticancer Drug Cisplatin J. Biol. Chem., July 6, 2001; 276(28): 25736 - 25741. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hohl, O. Christensen, C. Kunz, H. Naegeli, and O. Fleck Binding and Repair of Mismatched DNA Mediated by Rhp14, the Fission Yeast Homologue of Human XPA J. Biol. Chem., August 10, 2001; 276(33): 30766 - 30772. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |